Effect of rosuvastatin on diabetic polyneuropathy: a randomized, double-blind, placebo-controlled Phase IIa study

BACKGROUND: Diabetic neuropathy affects 50%–66% of patients with diabetes mellitus. Oxidative stress generates nerve dysfunction by causing segmental demyelinization and axonal degeneration. Antioxidants are considered to be the only etiologic management for diabetic polyneuropathy, and statins such...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Hernández-Ojeda, Jaime, Román-Pintos, Luis Miguel, Rodríguez-Carrízalez, Adolfo Daniel, Troyo-Sanromán, Rogelio, Cardona-Muñoz, Ernesto Germán, Alatorre-Carranza, María del Pilar, Miranda-Díaz, Alejandra Guillermina
Формат: Artigo
Язык:Inglês
Опубликовано: Dove Medical Press 2014
Предметы:
Original Research
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4159311/
https://ncbi.nlm.nih.gov/pubmed/25214797
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DMSO.S65500
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы